Can Relyvrio reduce ALS symptoms?

Relyvrio was approved for the treatment of amyotrophic lateral sclerosis (ALS) after clinical trials showed it could slow declines in the ability to function and extend survival by several months. However, like other available ALS therapies, Relyvrio generally cannot reverse or reduce symptoms that already existed at the time of the treatment’s start.